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Morphological Changes of Poly(d,l-lactide-co-glycolide)/Hydroxyapatite
(PLGA/HAP) Particles with Loaded Clindamycin During Degradation Process
Morphological changes of 
PLGA/HAp/clindamycin particles indicate 
two mechanisms of degradation followed 
by release of the drug: (i) diffusion 
controlled by macromolecular interactions 
and (ii) surface and bulk erosions. These 
mechanisms allow control over the drug 
concentration within surrounding medium.
It was observed that primary 
formed sphere-like morphology of 
PLGA/HAp/clindamycin particles was 
changed fast. During the first day of 
degradation particles tend to aggregate, 
started to ingrowth into larger spheres and 
appearance of rod-like HAp was observed. 
During the next four days secondary 
formed sphere-like particles further 
changed its morphology into film-like 
structures. After the final formation of films, 
they were turned into porous structures 
with uniform distribution of size and shape 
of pores until the whole 30-days 
degradation period was finished. In 
addition to formation of surface, bulk pores 
were observed too. In the same time 
macromolecular properties of PLGA were 
changed very slow with the time of 
degradation.  
AIM
The main advantages of the application of controlled drug delivery are related to high medication efficiency, comfortable medication treatment, low 
probability for side effects and fast healing/low medication price. To obtain maximal benefits of this type of medication properties of the drug carrier and the 
way of release of the drug should be analyzed in details and adjusted to potential applications.
In this work, PLGA/HAp composite particles formed from biocompatible polymeric and osteoconductive ceramic phases were selected as carriers of 
clindamycin, antibiotic which is usually applied for the treatment of infectious bone tissue diseases. The main aim of this part of monitoring of the degradation 
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